Thursday, May 1, 2014

Hospira makes progress on plant problems, reports improved financials

In the past, Hospira ($HSP) competitors have been able to take advantage of the drugmaker's absence from a market because of its plant problems, filling the void and their pockets as well, at Hospira's expense. More recently it has been Hospira's chance to live large off of the quality issues of others. The company's improved Q1 earnings were, in part, due to "off contract" prices.
continue to read here

Florida Board of Pharmacy Board Conference Call Meeting Today, May 1, 2014 to discuss rule 1. Rule 64B16-27.700

May 1, 2014 Board Conference Call
Meeting Location:Telephone Conference Call

Meet Me #:
(888) 670-3525

Participation Code:
513-489-6685
4042 Bald Cypress Way
Tallahassee, FL 32399


Meeting Materials
FAR Notice (PDF) | Agenda (PDF)


 

Must Read: Consent Agreement Arizonia Board of Pharmacy and CBS Chem, Ltd. transactions involving Diamondback, Speciality Pharmacy Cedar Park, Texas, etc.

NABP has issued a report stressing that illegal online drug sellers are the most frequent conduits of counterfeit drugs and pose a continued threat to global public health.

As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: April 2014 (PDF), most of these rogue Internet drug outlets sell prescription drug products directly to consumers without requiring a valid prescription.

continue to read here

The Washington Post For more states, execution means improvisation as drug supplies dwindle

By and ,
Oklahoma’s bungled execution of convicted murderer Clayton Lockett on Tuesday was, in some ways, a medical experiment gone wrong.
In recent years, as pharmaceutical companies have halted sales of drugs used in executions, as legal challenges have mounted and medical groups have vowed to ostracize doctors who participate in sanctioned killings, states have found themselves winging it when it comes to carrying out lethal injections.
continue to read here